Furthermore, primary GBM typically exhibits EGFR duplication (34%) and phosphatase and tensin homolog (PTEN) mutations (24%), in contrast to secondary GBM characterized by TP53 alterations (65%) and IDH1 mutations (70%) [40]. This evidence concerns the gene PTEN and glioblastoma.